Axogen, Inc. — Director's Dealing 2018

Jun 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-11-13

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	M	15000	$14.85	Acquired	375248	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-01	Stock Option (right to purchase)	$14.85	M	15000	Disposed	2027-06-01	Common Stock (15000)	Direct
2018-06-01	Stock Option (right to purchase)	$49.65	A	4780	Acquired	2028-06-01	Common Stock (4780)	Direct

Footnotes

F1: The shares of common stock for Dr. Gold include 212,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family.

F2: Non-qualified stock option grant for service as Director on the Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the finalinstallment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grantdate.